Bicara Therapeutics (BCAX) Tax Provisions (2023 - 2026)
Bicara Therapeutics (BCAX) posted quarterly Tax Provisions of $52000.0 for Q1 2026, down 27.78% year-over-year from $72000.0 in Q1 2025, and down 1.89% quarter-over-quarter from $53000.0 in Q4 2025.
Bicara Therapeutics (BCAX) Tax Provisions (2023 - 2026) Analysis & Trends
Bicara Therapeutics' Tax Provisions history runs 4 years deep, the most recent figure standing at $52000.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 27.78% year-over-year to $52000.0; the TTM figure through Mar 2026 stood at $197000.0 (down 23.64% YoY), while the FY2025 annual figure was $217000.0, up 16.04% from the prior year.
- Tax Provisions for Q1 2026 stood at $52000.0, down from $53000.0 in the prior quarter.
- The five-year high for Tax Provisions was $186000.0 in Q4 2024, with the low at $1000.0 in Q1 2024.
- The 4-year median for Tax Provisions is $52000.0 (2025), against an average of $57625.0.
- Peak annual rise in Tax Provisions reached 7100.0% in 2025, while the deepest fall reached 71.51% in 2025.
- Bicara Therapeutics' Tax Provisions stood at $5000.0 in 2023, then jumped by 3620.0% to $186000.0 in 2024, then tumbled by 71.51% to $53000.0 in 2025, then slipped by 1.89% to $52000.0 in 2026.
- Business Quant data shows BCAX's Tax Provisions at $52000.0 in Q1 2026, $53000.0 in Q4 2025, and $40000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Bicara Therapeutics | 1.60 Bn | 1.60 Bn | - | 61,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61,000.00 |
| Mar 31, 2026 | 52,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 52,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 186,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 5,000.00 |